Bonn1997 wrote:Who gave us better value this year? Camby, Novak, and Kidd for $10 mil combined OR Amare for $20 mil?

Not to mention, $10 million for three players is not against $0. It's against the cap hold for each position, which is about $1.5 million for the three slots, right? So we're really talking $8.5 million.

knicks1248 wrote:

fishmike wrote:

BRIGGS wrote:10mm spent on Camby Novak and Kidd--and that will hurt us next year--it will lock us out of the bigger MLE.

exactly the amount the Knicks couldnt spend on Jeremy Lin. More excellent Knick management

you get 3 for the price of one, thats a no brainer..with our injury luck Lin goes down, and like last season were left in chaos at the position.

You guys act like there so many options we by pass, like there were a host of FA guards and Centers..
Lin is great, but not all that proven, didn't show durabilty, and your severely weak at the position.

Kidd wasn't plan A or B he was C, see that we didn't have options or a bunch a trade chips then.

I don't think this is a fair argument, 3 for the price of 1. Lin is improving, CLEARLY. Camby and Kidd are declining (though still very good players). Novak is just an incomplete player, serves a function and I like him but it is hard to believe he is here and not Lin. So, saying something is a no brainer is just a subjective way of trying to make a point with your 3 for 1 argument and attaching a phrase that removes debate to the argument.

Lin is not proven, but he did prove he could lead our team of nobodies. He did prove he belonged in the NBA. He proved he could score in the clutch, could pass, defend and see the floor better than any PG we've had here since Jackson. What kind of proof do you want from what is essentially a rookie? Look at Kylie Irving or other young players that had some injuries, are you going to judge them as not showing durability? Come on, we are talking about a Meniscus tear.

Look at how much Lin has improved. Can't go left - no longer a big problem and still improving. Too many TO's - doing quite well there though he is off the ball a lot and not really being utilized well. I'm not saying Lin was our everything, but that was the most exciting basketball I'd seen as a Knicks fan in YEARS and we let it walk. You reap what you sow.

And now, who is our #2 scorer? It is JR and he comes off the bench. How terrible is that? Lin could close and was clutch for us, we let that walk because...

What would we do right now to have a number 2 scorer who also can lead the team?

Dolan blew the Lin thing and many of us, including me, called it. He further compounded it by bringing in the Geriatric bunch, who I like, but not over Lin. The injuries many of us predicted have really destroyed any continuity that we've had and more. Talk about durability???

The league figured us out and the crazy rate the 3's were falling is behind us. I am pulling for us but talking about a championship now is laughable.

BRIGGS wrote:10mm spent on Camby Novak and Kidd--and that will hurt us next year--it will lock us out of the bigger MLE.

your premise is faulty.

amare is max player and has underperformed, even when healthy. he makes nobody better, especially melo.
melo is a max player and has underperformed. he makes nobody better, especially stat.
chandler got a ton of money-- and has underperformed.

all 3 played a total of 1 year of college ball collectively and the pro game makes you age more quickly physically because you are going up against bigger and stronger players.

Bonn1997 wrote:I don't know if Amare will ever play an NBA game again. If he does, he probably won't last more than a month or two. I'd much rather get out of his contract than out of Camby's, Kidd's, and Novak's.

I don't know if I agree. If Amar'e can give the team 10-15 minutes of highly effective play, there's value there. I understand you usually pay the guy who does that a tenth of what Amar'e gives, but the cost will be too high to get another team to take his contract. It's unfortunate that it played out this way but it is what it is. Maybe he walks away like H20 did

Solace wrote:

Bonn1997 wrote:Who gave us better value this year? Camby, Novak, and Kidd for $10 mil combined OR Amare for $20 mil?

Not to mention, $10 million for three players is not against $0. It's against the cap hold for each position, which is about $1.5 million for the three slots, right? So we're really talking $8.5 million.

CrushAlot wrote:

fishmike wrote:

BRIGGS wrote:10mm spent on Camby Novak and Kidd--and that will hurt us next year--it will lock us out of the bigger MLE.

exactly the amount the Knicks couldnt spend on Jeremy Lin. More excellent Knick management

Lin's deal is 5 mil for the first 2 years and 15 mil for year three. The Knicks will not have 10 mil committed to those three when the poison pill goes into in effect in year three. Camby will be done as his deal had a minimal third year commitment so a sign and trade could be done.

Im still trying to figure out what does kidd, camby, and novak have to do with lin..kidd was suppose to be lins mentor, camby was tysons back up, and novak got his bird rights..those 3 guys was not why we didn't sign lin..